文献速递肿瘤 PET/CT

18F-FDG PET/CT上的血管铸型征:儿童T淋巴母细胞淋巴瘤的特异性影像标志

Vasculature cast sign on 18F-FDG PET/CT: a specific imaging marker for pediatric T-lymphoblastic lymphoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-07-30

回顾性分析60例(≤21岁)前纵隔肿瘤患者的治疗前18F-FDG PET/CT,评估血管铸型征等参数鉴别T淋巴母细胞淋巴瘤(T-LBL)与非T-LBL的诊断效能。血管铸型征特异性97.2%、阳性预测值93.8%、敏感性62.5%,观察者内与观察者间一致性分别为0.91和0.83。多因素分析显示血管铸型征、肿瘤SUVmax及Dmax>6.85 cm为独立影像标志,联合模型AUC为0.943,简化评分0至3分的诊断率分别为0%、14.3%、40%和100%。

要点

  • 血管铸型征诊断T-LBL特异性97.2%、阳性预测值93.8%,敏感性62.5%。
  • 血管铸型征观察者内和观察者间一致性分别为0.91和0.83。
  • 血管铸型征、肿瘤SUVmax和Dmax>6.85 cm为T-LBL独立影像标志,联合模型AUC为0.943。

核心结论

  • 血管铸型征是T-LBL特异且可重复的PET/CT标志。

研究设计与样本

  • 回顾性分析60例(≤21岁)前纵隔肿瘤患者的治疗前18F-FDG PET/CT,比较T-LBL与非T-LBL组的影像参数诊断效能,并评估血管铸型征的观察者内和观察者间一致性。

主要发现

  • 血管铸型征见于15/24例T-LBL,特异性97.2%、阳性预测值93.8%、敏感性62.5%。
  • 血管铸型征观察者内和观察者间一致性分别为0.91和0.83。
  • T-LBL较非T-LBL肿瘤最大径(Dmax)更大、肿瘤或脾脏SUVmax更低、以SUVmax的41%为阈值的总或纵隔肿瘤代谢体积更高、主动脉弓包绕更常见。
  • 多因素logistic回归显示血管铸型征(OR 37.45,95%CI 1.83-767.64,p=0.019)、肿瘤SUVmax(OR 0.82,95%CI 0.69-0.97,p=0.023)和Dmax>6.85 cm(OR 16.67,95%CI 1.76-158.21,p=0.014)为T-LBL独立影像标志。
  • 联合上述参数的模型AUC为0.943(p<0.001),基于三个参数的简化评分0、1、2、3分诊断率分别为0%(0/8)、14.3%(3/21)、40%(6/15)、100%(15/15)。

关键数值与推荐

  • 血管铸型征诊断T-LBL:特异性97.2%,阳性预测值93.8%,敏感性62.5%。
  • 血管铸型征观察者内一致性0.91,观察者间一致性0.83。
  • 多因素OR:血管铸型征37.45(95%CI 1.83-767.64,p=0.019);肿瘤SUVmax 0.82(95%CI 0.69-0.97,p=0.023);Dmax>6.85 cm 16.67(95%CI 1.76-158.21,p=0.014)。
  • 联合模型AUC 0.943(p<0.001)。
  • 简化评分诊断率:0分0%(0/8)、1分14.3%(3/21)、2分40%(6/15)、3分100%(15/15)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the diagnostic performance of 18F-FDG PET/CT parameters for T-lymphoblastic lymphoma (T-LBL), with particular emphasis on the "vasculature cast" sign, for distinguishing T-LBL from other pediatric anterior mediastinal malignancies. METHODS: Pretreatment 18F-FDG PET/CT scan of 60 patients (≤ 21 years) with anterior mediastinal tumors were retrospectively analyzed. Diagnostic performance of the imaging parameters was compared between T-LBL and nonT-LBL groups. Intra- and interobserver agreement for vasculature cast sign was assessed. RESULTS: The vasculature cast sign was present in 15/24 T-LBL cases, with high specificity (97.2%) and positive predictive value (93.8%) but moderate sensitivity (62.5%). Intra- and interobserver agreement were 0.91 and 0.83, respectively. T-LBL had significantly larger tumor dimension (Dmax), lower SUVmax of the tumor or the spleen, higher total or mediastinal tumor metabolic tumor volume with a threshold of 41% of SUVmax and more frequent aortic arch encasement compared to nonT-LBL. Multivariable logistic regression identified the vasculature cast sign (odds ratio [OR], 37.45, 95% CI: 1.83-767.64, p = 0.019), tumor SUVmax (OR, 0.82, 95% CI: 0.69-0.97, p = 0.023) and Dmax > 6.85 cm (OR, 16.67; 95% CI: 1.76-158.21, p = 0.014) as independent imaging markers for T-LBL. Model combining these parameters yielded an area under the curve of 0.943 (p < 0.001), and a simplified scoring system was developed based on the three parameters, yielding the diagnostic rates of 0% (0/8), 14.3% (3/21), 40% (6/15), and 100% (15/15) for scores of 0, 1, 2, and 3, respectively. CONCLUSION: The vasculature cast sign is a specific and reproducible PET/CT marker of T-LBL.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhang H, Li C, Chen Y, et al. Vasculature cast sign on 18F-FDG PET/CT: a specific imaging marker for pediatric T-lymphoblastic lymphoma. Eur J Nucl Med Mol Imaging. 2025. PMID: 40736563. doi:10.1007/s00259-025-07488-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。